Pfizer to Sell Capsugel Unit to KKR for $2.38 Billion

Pfizer to Sell Capsugel Unit to KKR for $2.38 Billion Play

April 4 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, agreed to sell its Capsugel business to KKR & Co. for $2.38 billion in cash, said it will buy back additional shares and lowered its revenue forecasts. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

blog comments powered by Disqus